Ovation Research Group Creates Ovationet
HIGHLAND PARK, ILL-Ovation Research Group has formed a new company, Ovationet, to provide on-line consumer-oriented outcomes registries for individuals with chronic diseases. Operating as Invida Outcomes Network, the company hopes to launch its site in the third quarter of 2000 at www.invida.com. The president of Ovation Research Group and chairman of Invida, Jeffrey Trotter, said, "Invida will help patients and their healthcare providers monitor and manage chronic conditions by making outcomes research more accessible and meaningful to them. Patients know best how compliant they are with therapies, how medications help them, and how they feel about their lives. By aggregating this information with thousands of others with the same chronic conditions, we will provide invaluable information for patients to share with their healthcare providers and families."
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.